Xiangdong Xu

2.5k total citations
48 papers, 1.6k citations indexed

About

Xiangdong Xu is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiangdong Xu has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Xiangdong Xu's work include Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers) and RNA and protein synthesis mechanisms (4 papers). Xiangdong Xu is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Viral-associated cancers and disorders (4 papers) and RNA and protein synthesis mechanisms (4 papers). Xiangdong Xu collaborates with scholars based in United States, China and France. Xiangdong Xu's co-authors include Xiang‐Dong Fu, Huan‐You Wang, John R. Bermingham, Pao‐Hsien Chu, John Ross, Nancy D. Dalton, Dongmei Yang, Heping Cheng, Ju Chen and Mei Kong and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Xiangdong Xu

41 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangdong Xu United States 18 1.1k 413 201 146 119 48 1.6k
Xiao Yue China 24 1.2k 1.1× 1.0k 2.5× 125 0.6× 146 1.0× 153 1.3× 37 1.7k
Damien Gerald United States 10 973 0.8× 553 1.3× 376 1.9× 205 1.4× 52 0.4× 16 1.5k
Sabine Müller‐Brüsselbach Germany 22 982 0.9× 460 1.1× 326 1.6× 488 3.3× 137 1.2× 40 1.7k
Magdalena Bachvarova Canada 22 718 0.6× 255 0.6× 245 1.2× 229 1.6× 65 0.5× 35 1.2k
Susana Constantino Rosa Santos Portugal 17 664 0.6× 250 0.6× 464 2.3× 224 1.5× 63 0.5× 41 1.3k
Jiyun Yoo South Korea 23 1.2k 1.1× 245 0.6× 413 2.1× 129 0.9× 49 0.4× 53 1.8k
Daniel T. Dransfield United States 18 780 0.7× 223 0.5× 283 1.4× 139 1.0× 60 0.5× 46 1.2k
Rosana Meyer United States 23 1.1k 0.9× 220 0.5× 308 1.5× 187 1.3× 36 0.3× 37 1.4k
Severa Bunda Canada 18 608 0.5× 177 0.4× 150 0.7× 196 1.3× 50 0.4× 27 1.0k
Esther Bridges United Kingdom 21 1.1k 1.0× 744 1.8× 430 2.1× 190 1.3× 33 0.3× 38 1.7k

Countries citing papers authored by Xiangdong Xu

Since Specialization
Citations

This map shows the geographic impact of Xiangdong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangdong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangdong Xu more than expected).

Fields of papers citing papers by Xiangdong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangdong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangdong Xu. The network helps show where Xiangdong Xu may publish in the future.

Co-authorship network of co-authors of Xiangdong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangdong Xu. A scholar is included among the top collaborators of Xiangdong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangdong Xu. Xiangdong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Yi, Zhixin Guo, Jianyan Long, et al.. (2025). Surgical Optimization in Preoperatively Low-risk cN1a PTC: A Predictive Model for High-Volume Central Lymph Node Metastasis. Annals of Surgical Oncology. 33(2). 1307–1318.
3.
Li, Jing, et al.. (2024). Covalent immobilization of lipase on moderately hydrophilic gigaporous polystyrene microspheres for efficient biosynthesis of benzyl cinnamate. Journal of environmental chemical engineering. 12(5). 113443–113443. 2 indexed citations
4.
Kerman, Bilal E., Stéphane Genoud, Ahmet M. Denli, et al.. (2020). Motoneuron expression profiling identifies an association between an axonal splice variant of HDGF-related protein 3 and peripheral myelination. Journal of Biological Chemistry. 295(34). 12233–12246. 1 indexed citations
5.
Gabra, Mari B. Ishak, Ying Yang, Haiqing Li, et al.. (2020). Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growth. Nature Communications. 11(1). 3326–3326. 74 indexed citations
6.
Zhou, Wei, Phillip Kyriakakis, Yiqian Wu, et al.. (2019). An AND-Gated Drug and Photoactivatable Cre-loxP System for Spatiotemporal Control in Cell-Based Therapeutics. ACS Synthetic Biology. 8(10). 2359–2371. 27 indexed citations
7.
Tom, W. James, et al.. (2019). Follicular pancreatitis: A rare pancreatic inflammatory pseudotumor. Clinical Imaging. 59(1). 39–44. 2 indexed citations
8.
Xu, Xiangdong, et al.. (2019). Design and evaluation of pyrazolopyrimidines as KCNQ channel modulators. Bioorganic & Medicinal Chemistry Letters. 29(19). 126603–126603. 11 indexed citations
9.
Li, F., Yuqin Yang, Xiangdong Xu, et al.. (2018). IGFBP2 promotes vasculogenic mimicry formation via regulating CD144 and MMP2 expression in glioma. Oncogene. 38(11). 1815–1831. 86 indexed citations
10.
Pan, Min, Michael A. Reid, Xazmin H. Lowman, et al.. (2016). Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation. Nature Cell Biology. 18(10). 1090–1101. 276 indexed citations
11.
Xu, Xiangdong, et al.. (2015). Atypical presentation of Whipple disease with no diarrhea. Indian Journal of Pathology and Microbiology. 58(3). 398–398. 1 indexed citations
12.
Wu, Ridong, Chen Yao, Xiangdong Xu, et al.. (2014). Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arterial disease: A meta-analysis of randomized trials. Journal of Vascular Surgery. 59(6). 1711–1720. 30 indexed citations
13.
Tan, Bing, Jinxiang Tan, Zhen Quan, et al.. (2014). HepaCAM inhibits clear cell renal carcinoma 786-0 cell proliferation via blocking PKCε translocation from cytoplasm to plasma membrane. Molecular and Cellular Biochemistry. 391(1-2). 95–102. 13 indexed citations
14.
Xu, Xiangdong, Friederike Kreisel, John L. Frater, & Anjum Hassan. (2014). Mast cell leukemia with prolonged survival on PKC412/midostaurin.. PubMed. 7(6). 3439–43.
15.
Schmitt, Michael, Xiangdong Xu, Inken Hilgendorf, et al.. (2013). Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors. Bone Marrow Transplantation. 48(7). 922–925. 24 indexed citations
16.
Pan, Fu‐shun, et al.. (2012). Comparison of empirical estimate of clinical pretest probability with the Wells score for diagnosis of deep vein thrombosis. Blood Coagulation & Fibrinolysis. 24(1). 76–81. 6 indexed citations
17.
Waring, Jeffrey F., Yi Yang, Andrew Adler, et al.. (2007). Gene Expression Analysis in Rats Treated with Experimental Acetyl-Coenzyme A Carboxylase Inhibitors Suggests Interactions with the Peroxisome Proliferator-Activated Receptor α Pathway. Journal of Pharmacology and Experimental Therapeutics. 324(2). 507–516. 17 indexed citations
18.
Yeo, G, Xiangdong Xu, Tiffany Y Liang, et al.. (2007). Alternative Splicing Events Identified in Human Embryonic Stem Cells and Neural Progenitors. PLoS Computational Biology. 3(10). e196–e196. 101 indexed citations
19.
Xu, Xiangdong, Dongmei Yang, Wang Wang, et al.. (2005). ASF/SF2-Regulated CaMKIIδ Alternative Splicing Temporally Reprograms Excitation-Contraction Coupling in Cardiac Muscle. Cell. 120(1). 59–72. 295 indexed citations
20.
Wang, Huan‐You, et al.. (2001). SC35 Plays a Role in T Cell Development and Alternative Splicing of CD45. Molecular Cell. 7(2). 331–342. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026